Angina Clinical Trials

A listing of Angina medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 47 clinical trials
Efficacy of Medical Therapy in Women and Men With Angina and Myocardial Bridging

with angina in the absence of obstructive CAD who currently remain undiagnosed and untreated. It, therefore, upholds an important part of the mission of the The National Heart, Lung, and Blood

  • 0 views
  • 04 Oct, 2022
  • 1 location
Coronary Computed Tomographic Angiography in Intermediate-risk Chest Pain Patients

pain reduces the composite endpoint of death, readmission because of myocardial infarction or unstable angina requiring revascularization.

infarct
artery disease
revascularisation
unstable angina
angiography
  • 0 views
  • 04 Oct, 2022
  • 1 location
Firehawk Rapamycin Target Eluting Coronary Stent North American Trial

treatment of subjects with ischemic heart disease (NSTEMI, recent STEMI (>24 hours from initial presentation and in whom enzyme levels have peaked), unstable angina, and stable coronary disease), with

troponin
zotarolimus
coronary disease
heart disease
biodegradable polymer
  • 7 views
  • 04 Oct, 2022
  • 25 locations
A Randomised Controlled Trial of Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis (EASY-AS)

the AS. Ultimately, compensatory mechanisms fail resulting in angina, syncope or heart failure. If these symptomatic patients with severe AS remain untreated, they have a dire prognosis. In this

angina pectoris
tavi
aortic valve replacement
stenosis
syncope
  • 0 views
  • 16 Oct, 2022
  • 47 locations
The TransCatheter Valve and Vessels Trial (TCW)

The trial objective is to investigate whether Fractional Flow Reserve (FFR)-Guided Percutaneous Coronary Intervention (PCI) and TransCatheter Aortic Valve Implantation (TAVI) strategy for treatment of multivessel disease and aortic stenosis will be non-inferior to Coronary Artery By-pass Grafting (CABG) and Surgical Aortic Valve Replacement (SAVR) for a composite primary endpoint …

infarct
stroke
coronary artery bypass graft
aortic valve replacement
myocardial infarction
  • 55 views
  • 04 Oct, 2022
  • 20 locations
Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT (MINOCA-BAT)

Myocardial infarction with non-obstructive coronary arteries" (MINOCA) occurs in 5-10% of all patients with AMI. There are neither any randomized clinical trials in MINOCA patients evaluating effects of secondary preventive treatments proven beneficial in patients with classic AMI, nor any treatment guidelines. The primary objective of this multi-national, multi-center pragmatic …

  • 6 views
  • 07 Oct, 2022
  • 31 locations
Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial

Previous randomized clinical trials have deomonstrated the efficacy and safety of short-term dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI), however, the single antiplatelet agent to be maintained after short-term DAPT was different. Therefore, which antiplatelet agent to be maintained after short-term DAPT needs further invstigations.

  • 0 views
  • 22 Oct, 2022
  • 1 location
Efficacy of Spinal Cord Stimulation in Patients With Refractory Angina Pectoris (SCRAP)

There are a growing number of patients with refractory angina pectoris (RAP). RAP is defined as a 'chronic condition (> three months) characterized by diffuse coronary artery disease in the

  • 0 views
  • 04 Oct, 2022
  • 1 location
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II (COSIRA-II)

To demonstrate the safety and effectiveness of the Reducer system for treatment of patients with refractory angina pectoris treated with maximally tolerated guideline-directed medical therapy

  • 0 views
  • 07 Oct, 2022
  • 12 locations
A Placebo-controlled Trial of Percutaneous Coronary Intervention for the Relief of Stable Angina (ORBITA-2)

ORBITA-2 is a double blinded randomised placebo-controlled trial comparing the effects of coronary angioplasty versus placebo procedure on symptoms of stable angina without background anti

stress echocardiography
anti-anginal
coronary angioplasty
cardiac mri
angina pectoris
  • 60 views
  • 07 Oct, 2022
  • 8 locations